Singapore markets closed

CVS Health Corporation (CVS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
77.20+0.10 (+0.13%)
At close: 04:00PM EST
77.19 -0.01 (-0.01%)
After hours: 07:50PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 97.15B
Enterprise value 165.08B
Trailing P/E 11.93
Forward P/E 9.29
PEG Ratio (5 yr expected) 1.12
Price/sales (ttm)0.28
Price/book (mrq)1.27
Enterprise value/revenue 0.46
Enterprise value/EBITDA 9.07

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 3-9.01%
S&P500 52-week change 327.79%
52-week high 386.28
52-week low 364.41
50-day moving average 376.45
200-day moving average 371.67

Share statistics

Avg vol (3-month) 311.26M
Avg vol (10-day) 39.63M
Shares outstanding 51.26B
Implied shares outstanding 61.26B
Float 81.25B
% held by insiders 10.15%
% held by institutions 183.04%
Shares short (31 Jan 2024) 436.79M
Short ratio (31 Jan 2024) 42.58
Short % of float (31 Jan 2024) 42.93%
Short % of shares outstanding (31 Jan 2024) 42.92%
Shares short (prior month 29 Dec 2023) 416.45M

Dividends & splits

Forward annual dividend rate 42.66
Forward annual dividend yield 43.45%
Trailing annual dividend rate 32.42
Trailing annual dividend yield 33.14%
5-year average dividend yield 42.87
Payout ratio 437.40%
Dividend date 301 Feb 2024
Ex-dividend date 419 Jan 2024
Last split factor 22:1
Last split date 307 Jun 2005

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 2.34%
Operating margin (ttm)3.67%

Management effectiveness

Return on assets (ttm)3.68%
Return on equity (ttm)11.28%

Income statement

Revenue (ttm)356.62B
Revenue per share (ttm)277.53
Quarterly revenue growth (yoy)12.00%
Gross profit (ttm)N/A
EBITDA 18.44B
Net income avi to common (ttm)8.34B
Diluted EPS (ttm)6.47
Quarterly earnings growth (yoy)-12.30%

Balance sheet

Total cash (mrq)11.45B
Total cash per share (mrq)9.1
Total debt (mrq)79.39B
Total debt/equity (mrq)103.59%
Current ratio (mrq)0.86
Book value per share (mrq)59.36

Cash flow statement

Operating cash flow (ttm)13.43B
Levered free cash flow (ttm)11.08B